| Net Cash Provided by (Used in) Operating Activities |
$10,550,000 |
USD |
-27% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$70,372,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$70,309,000 |
USD |
-11445% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
141,250,000 |
shares |
|
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
31,050,000 |
shares |
|
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$10,584,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$18,182,000 |
USD |
35% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$2,650,000 |
USD |
57% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Gross |
$10,083,000 |
USD |
4% |
Q3 2025 |
Q3 2025 |
| Depreciation |
$60,861,000 |
USD |
11% |
Q3 2025 |
Q3 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$2,767,000 |
USD |
62% |
Q3 2025 |
Q3 2025 |
| Deferred Income Tax Expense (Benefit) |
$1,124,000 |
USD |
92% |
Q3 2025 |
Q3 2025 |
| Deferred Federal Income Tax Expense (Benefit) |
$337,000 |
USD |
78% |
Q3 2025 |
Q3 2025 |
| Current Income Tax Expense (Benefit) |
$806,000 |
USD |
40% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Authorized |
50,000,000 |
shares |
|
Q2 2025 |
Q3 2025 |
| Current State and Local Tax Expense (Benefit) |
$39,000 |
USD |
58% |
Q3 2025 |
Q3 2025 |
| Current Federal Tax Expense (Benefit) |
$1,000 |
USD |
-100% |
Q3 2025 |
Q3 2025 |
| Amortization of Intangible Assets |
$6,906,000 |
USD |
341% |
Q3 2025 |
Q3 2025 |
| Deferred State and Local Income Tax Expense (Benefit) |
$1,000 |
USD |
-119% |
Q3 2025 |
Q3 2025 |
| Interest Expense |
$65,948,000 |
USD |
-4.7% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Q2 2025 |
Q3 2025 |